Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone pharmacokinetics in Japanese cancer inpatients with renal impairment
jRCT1061190042Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hydromorphone in cancer pain, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Total body clearance at steady state of hydromorphone. Started Apr 2020; status: completed.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT1061190042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061190042.